FDA Proposes Tougher Guidelines For Advisers

Law360, New York (March 21, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration released draft guidelines Wednesday that would keep individuals with interests of over $50,000 in drug and medical device companies from participating in the agency’s advisory committees.

The FDA said the guidelines, which are subject to public comment for 60 days before they are finalized, are part of its new stricter line against potential conflicts of interest for its advisory committee members.

“FDA is committed to making the advisory committee process more rigorous and transparent so that the public has confidence...
To view the full article, register now.